2026 BCPMP Exam Prep: Pain Management
Pharmacist Practice Questions, Answer
Rationales, Opioid Therapy, Analgesics, Chronic
Pain Pharmacotherapy, Safety & Clinical
Management Study Guide
DOMAIN 1: PATHOPHYSIOLOGY AND PATIENT ASSESSMENT
(Questions 1–20)
Question 1
A 58-year-old patient with diabetic peripheral neuropathy describes their pain as
"burning and shooting" in both feet. The pharmacist understands this pain is
primarily mediated by which mechanism?
A) Nociceptive pain from tissue damage
B) Neuropathic pain from somatosensory nervous system lesion or disease
C) Nociplastic pain from altered central processing
D) Referred visceral pain
Rationale: Neuropathic pain is defined as pain caused by a lesion or disease of the
somatosensory nervous system. Diabetic peripheral neuropathy is a classic
example, with burning, shooting, and electric-shock-like descriptors. Nociceptive
pain results from actual or threatened damage to non-neural tissue. Nociplastic
pain arises from altered nociception without clear evidence of tissue or nerve
damage, as seen in fibromyalgia.
Question 2
A pharmacist is assessing a patient with chronic low back pain using the PEG
scale. The patient scores 4 on pain intensity, 5 on enjoyment of life, and 6 on
general activity. What is the total PEG score and its interpretation?
A) 15; severe impact
B) 5; moderate impact
,C) 10; severe impact
D) 6; mild impact
Rationale: The PEG (Pain, Enjoyment of life, General activity) scale is a three-
item tool scored 0–10 for each item, with a total score of 0–30. The total score is
calculated by averaging the three scores (4 + 5 + 6 = 15 ÷ 3 = 5). A score of 5
indicates moderate impact on function. Scores of 0–3 indicate low impact, 4–6
moderate impact, and 7–10 severe impact.
Question 3
Which screening tool is MOST appropriate for assessing a patient's risk of opioid
misuse before initiating long-term opioid therapy?
A) PHQ-9
B) Opioid Risk Tool (ORT)
C) GAD-7
D) CAGE questionnaire
Rationale: The Opioid Risk Tool (ORT) is a validated screening tool specifically
designed to assess a patient's risk for opioid misuse before initiating long-term
opioid therapy. It evaluates personal and family history of substance abuse,
psychological disease, and age. A score of 0–3 indicates low risk, 4–7 intermediate
risk, and 8 or higher high risk. The PHQ-9 screens for depression, the GAD-7 for
anxiety, and CAGE for alcohol use.
Question 4
A pharmacist is evaluating a patient with chronic pain who reports that their pain is
"always there" but varies in intensity from 3/10 to 8/10 throughout the day. This
pattern is MOST consistent with:
A) Acute pain
B) Persistent (chronic) pain with exacerbations
C) Breakthrough pain only
D) Referred pain
Rationale: Persistent (chronic) pain is characterized by continuous pain that may
fluctuate in intensity. Breakthrough pain refers to transient exacerbations of pain
that occur despite otherwise adequate baseline analgesia. The patient's description
,of constant pain with varying intensity is consistent with chronic pain with
exacerbations.
Question 5
A patient with cancer-related bone pain reports sudden severe back pain, new
lower extremity weakness, and urinary retention. What is the pharmacist's MOST
appropriate action?
A) Recommend increasing the opioid dose
B) Recognize this as a medical emergency requiring immediate provider
notification for suspected spinal cord compression
C) Recommend adding an NSAID to the regimen
D) Suggest referral to physical therapy
Rationale: Sudden severe back pain with new lower extremity weakness and
urinary retention in a patient with bone metastases indicates suspected spinal cord
compression, a medical emergency requiring immediate provider notification and
imaging. Delay in treatment can result in permanent paralysis. Opioid dose
increases, NSAIDs, and physical therapy do not address the underlying emergency.
Question 6
A pharmacist is using the SOAPP-R (Screener and Opioid Assessment for Patients
with Pain-Revised) to assess a patient. What is the primary purpose of this tool?
A) To measure pain intensity
B) To predict aberrant medication-related behaviors in patients with chronic
pain
C) To assess functional status
D) To diagnose opioid use disorder
Rationale: The SOAPP-R is a validated screening tool designed to predict aberrant
medication-related behaviors in patients being considered for long-term opioid
therapy. It is a self-administered questionnaire that assesses factors such as
substance use history, psychological distress, and medication-related behaviors. It
does not measure pain intensity, assess functional status, or diagnose opioid use
disorder.
, Question 7
A pharmacist is assessing a patient with chronic pain who reports symptoms of
depression, anxiety, and PTSD. According to the biopsychosocial model, which
factor is MOST important to address?
A) Psychological comorbidities that may amplify pain perception and
interfere with treatment
B) Only the physical symptoms of pain
C) The patient's employment status
D) The patient's marital status
Rationale: The biopsychosocial model recognizes that pain is influenced by
biological, psychological, and social factors. Psychological comorbidities such as
depression, anxiety, and PTSD can amplify pain perception, interfere with
treatment adherence, and worsen outcomes. Addressing these comorbidities is
essential for comprehensive pain management.
Question 8
A patient with chronic pain reports that their pain is "10 out of 10" but is smiling
and conversing with visitors. What is the pharmacist's MOST appropriate
interpretation?
A) The patient is not actually in pain
B) The patient's self-report is the most reliable indicator of pain intensity
C) The patient is seeking attention
D) The patient is experiencing anxiety, not pain
Rationale: The patient's self-report is the most reliable indicator of pain intensity.
Patients may use distraction, social interaction, or other coping mechanisms to
manage their pain. The pharmacist should accept the self-report and provide
appropriate intervention without questioning its validity.
Question 9
A pharmacist is evaluating a patient with suspected nociplastic pain. Which
condition is the BEST example of nociplastic pain?
A) Osteoarthritis
B) Diabetic neuropathy
Pharmacist Practice Questions, Answer
Rationales, Opioid Therapy, Analgesics, Chronic
Pain Pharmacotherapy, Safety & Clinical
Management Study Guide
DOMAIN 1: PATHOPHYSIOLOGY AND PATIENT ASSESSMENT
(Questions 1–20)
Question 1
A 58-year-old patient with diabetic peripheral neuropathy describes their pain as
"burning and shooting" in both feet. The pharmacist understands this pain is
primarily mediated by which mechanism?
A) Nociceptive pain from tissue damage
B) Neuropathic pain from somatosensory nervous system lesion or disease
C) Nociplastic pain from altered central processing
D) Referred visceral pain
Rationale: Neuropathic pain is defined as pain caused by a lesion or disease of the
somatosensory nervous system. Diabetic peripheral neuropathy is a classic
example, with burning, shooting, and electric-shock-like descriptors. Nociceptive
pain results from actual or threatened damage to non-neural tissue. Nociplastic
pain arises from altered nociception without clear evidence of tissue or nerve
damage, as seen in fibromyalgia.
Question 2
A pharmacist is assessing a patient with chronic low back pain using the PEG
scale. The patient scores 4 on pain intensity, 5 on enjoyment of life, and 6 on
general activity. What is the total PEG score and its interpretation?
A) 15; severe impact
B) 5; moderate impact
,C) 10; severe impact
D) 6; mild impact
Rationale: The PEG (Pain, Enjoyment of life, General activity) scale is a three-
item tool scored 0–10 for each item, with a total score of 0–30. The total score is
calculated by averaging the three scores (4 + 5 + 6 = 15 ÷ 3 = 5). A score of 5
indicates moderate impact on function. Scores of 0–3 indicate low impact, 4–6
moderate impact, and 7–10 severe impact.
Question 3
Which screening tool is MOST appropriate for assessing a patient's risk of opioid
misuse before initiating long-term opioid therapy?
A) PHQ-9
B) Opioid Risk Tool (ORT)
C) GAD-7
D) CAGE questionnaire
Rationale: The Opioid Risk Tool (ORT) is a validated screening tool specifically
designed to assess a patient's risk for opioid misuse before initiating long-term
opioid therapy. It evaluates personal and family history of substance abuse,
psychological disease, and age. A score of 0–3 indicates low risk, 4–7 intermediate
risk, and 8 or higher high risk. The PHQ-9 screens for depression, the GAD-7 for
anxiety, and CAGE for alcohol use.
Question 4
A pharmacist is evaluating a patient with chronic pain who reports that their pain is
"always there" but varies in intensity from 3/10 to 8/10 throughout the day. This
pattern is MOST consistent with:
A) Acute pain
B) Persistent (chronic) pain with exacerbations
C) Breakthrough pain only
D) Referred pain
Rationale: Persistent (chronic) pain is characterized by continuous pain that may
fluctuate in intensity. Breakthrough pain refers to transient exacerbations of pain
that occur despite otherwise adequate baseline analgesia. The patient's description
,of constant pain with varying intensity is consistent with chronic pain with
exacerbations.
Question 5
A patient with cancer-related bone pain reports sudden severe back pain, new
lower extremity weakness, and urinary retention. What is the pharmacist's MOST
appropriate action?
A) Recommend increasing the opioid dose
B) Recognize this as a medical emergency requiring immediate provider
notification for suspected spinal cord compression
C) Recommend adding an NSAID to the regimen
D) Suggest referral to physical therapy
Rationale: Sudden severe back pain with new lower extremity weakness and
urinary retention in a patient with bone metastases indicates suspected spinal cord
compression, a medical emergency requiring immediate provider notification and
imaging. Delay in treatment can result in permanent paralysis. Opioid dose
increases, NSAIDs, and physical therapy do not address the underlying emergency.
Question 6
A pharmacist is using the SOAPP-R (Screener and Opioid Assessment for Patients
with Pain-Revised) to assess a patient. What is the primary purpose of this tool?
A) To measure pain intensity
B) To predict aberrant medication-related behaviors in patients with chronic
pain
C) To assess functional status
D) To diagnose opioid use disorder
Rationale: The SOAPP-R is a validated screening tool designed to predict aberrant
medication-related behaviors in patients being considered for long-term opioid
therapy. It is a self-administered questionnaire that assesses factors such as
substance use history, psychological distress, and medication-related behaviors. It
does not measure pain intensity, assess functional status, or diagnose opioid use
disorder.
, Question 7
A pharmacist is assessing a patient with chronic pain who reports symptoms of
depression, anxiety, and PTSD. According to the biopsychosocial model, which
factor is MOST important to address?
A) Psychological comorbidities that may amplify pain perception and
interfere with treatment
B) Only the physical symptoms of pain
C) The patient's employment status
D) The patient's marital status
Rationale: The biopsychosocial model recognizes that pain is influenced by
biological, psychological, and social factors. Psychological comorbidities such as
depression, anxiety, and PTSD can amplify pain perception, interfere with
treatment adherence, and worsen outcomes. Addressing these comorbidities is
essential for comprehensive pain management.
Question 8
A patient with chronic pain reports that their pain is "10 out of 10" but is smiling
and conversing with visitors. What is the pharmacist's MOST appropriate
interpretation?
A) The patient is not actually in pain
B) The patient's self-report is the most reliable indicator of pain intensity
C) The patient is seeking attention
D) The patient is experiencing anxiety, not pain
Rationale: The patient's self-report is the most reliable indicator of pain intensity.
Patients may use distraction, social interaction, or other coping mechanisms to
manage their pain. The pharmacist should accept the self-report and provide
appropriate intervention without questioning its validity.
Question 9
A pharmacist is evaluating a patient with suspected nociplastic pain. Which
condition is the BEST example of nociplastic pain?
A) Osteoarthritis
B) Diabetic neuropathy
